BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11509645)

  • 1. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis.
    Long SA; Quan C; Van de Water J; Nantz MH; Kurth MJ; Barsky D; Colvin ME; Lam KS; Coppel RL; Ansari A; Gershwin ME
    J Immunol; 2001 Sep; 167(5):2956-63. PubMed ID: 11509645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies.
    Leung PS; Quan C; Park O; Van de Water J; Kurth MJ; Nantz MH; Ansari AA; Coppel RL; Lam KS; Gershwin ME
    J Immunol; 2003 May; 170(10):5326-32. PubMed ID: 12734383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA.
    Leung PS; Wang J; Naiyanetr P; Kenny TP; Lam KS; Kurth MJ; Gershwin ME
    J Autoimmun; 2013 Mar; 41():79-86. PubMed ID: 23352659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid.
    Amano K; Leung PS; Rieger R; Quan C; Wang X; Marik J; Suen YF; Kurth MJ; Nantz MH; Ansari AA; Lam KS; Zeniya M; Matsuura E; Coppel RL; Gershwin ME
    J Immunol; 2005 May; 174(9):5874-83. PubMed ID: 15845458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The X and why of xenobiotics in primary biliary cirrhosis.
    Rieger R; Gershwin ME
    J Autoimmun; 2007; 28(2-3):76-84. PubMed ID: 17360156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirement for autoreactivity on human pyruvate dehydrogenase-E2, the major autoantigen of primary biliary cirrhosis. Implication for a conformational autoepitope.
    Surh CD; Coppel R; Gershwin ME
    J Immunol; 1990 May; 144(9):3367-74. PubMed ID: 1691756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoepitope mapping and reactivity of autoantibodies to the dihydrolipoamide dehydrogenase-binding protein (E3BP) and the glycine cleavage proteins in primary biliary cirrhosis.
    Dubel L; Tanaka A; Leung PS; Van de Water J; Coppel R; Roche T; Johanet C; Motokawa Y; Ansari A; Gershwin ME
    Hepatology; 1999 Apr; 29(4):1013-8. PubMed ID: 10094940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative epitope mapping of murine monoclonal and human autoantibodies to human PDH-E2, the major mitochondrial autoantigen of primary biliary cirrhosis.
    Surh CD; Ahmed-Ansari A; Gershwin ME
    J Immunol; 1990 Apr; 144(7):2647-52. PubMed ID: 1690773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A lipoyl synthetic octadecapeptide of dihydrolipoamide acetyltransferase specifically recognized by anti-M2 autoantibodies in primary biliary cirrhosis.
    Tuaillon N; Andre C; Briand JP; Penner E; Muller S
    J Immunol; 1992 Jan; 148(2):445-50. PubMed ID: 1729364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies.
    Moteki S; Leung PS; Coppel RL; Dickson ER; Kaplan MM; Munoz S; Gershwin ME
    Hepatology; 1996 Jul; 24(1):97-103. PubMed ID: 8707289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of PDC-E2 human combinatorial autoantibodies by peptide mimotopes.
    Leung PS; Cha S; Joplin RE; Galperin C; Van de Water J; Ansari AA; Coppel RL; Schatz PJ; Cwirla S; Fabris LE; Neuberger JM; Gershwin ME
    J Autoimmun; 1996 Dec; 9(6):785-93. PubMed ID: 9115581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell responses to the putative dominant autoepitope in primary biliary cirrhosis (PBC).
    Palmer JM; Diamond AG; Yeaman SJ; Bassendine MF; Jones DE
    Clin Exp Immunol; 1999 Apr; 116(1):133-9. PubMed ID: 10209517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: searching for a mimic.
    Sasaki M; Ansari A; Pumford N; van de Water J; Leung PS; Humphries KM; Szweda LI; Nakanuma Y; Roche TE; Coppel RL; Bach JF; Gershwin ME
    J Autoimmun; 2000 Aug; 15(1):51-60. PubMed ID: 10936028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex.
    Moteki S; Leung PS; Dickson ER; Van Thiel DH; Galperin C; Buch T; Alarcon-Segovia D; Kershenobich D; Kawano K; Coppel RL
    Hepatology; 1996 Mar; 23(3):436-44. PubMed ID: 8617422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution to antimitochondrial antibody production: cleavage of pyruvate dehydrogenase complex-E2 by apoptosis-related proteases.
    Matsumura S; Van De Water J; Kita H; Coppel RL; Tsuji T; Yamamoto K; Ansari AA; Gershwin ME
    Hepatology; 2002 Jan; 35(1):14-22. PubMed ID: 11786955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactivity of porcine heart dihydrolipoamide acetyl- and succinyl-transferases (PDC-E2, OGDC-E2) with primary biliary cirrhosis sera: characterization of the autoantigenic region and effects of enzymatic delipoylation and relipoylation.
    Koike K; Ishibashi H; Koike M
    Hepatology; 1998 Jun; 27(6):1467-74. PubMed ID: 9620315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Random phage mimotopes recognized by monoclonal antibodies against the pyruvate dehydrogenase complex-E2 (PDC-E2).
    Cha S; Leung PS; Van de Water J; Tsuneyama K; Joplin RE; Ansari AA; Nakanuma Y; Schatz PJ; Cwirla S; Fabris LE; Neuberger JM; Gershwin ME; Coppel RL
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10949-54. PubMed ID: 8855289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible.
    Amano K; Leung PS; Xu Q; Marik J; Quan C; Kurth MJ; Nantz MH; Ansari AA; Lam KS; Zeniya M; Coppel RL; Gershwin ME
    J Immunol; 2004 May; 172(10):6444-52. PubMed ID: 15128836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine specificity of T cells reactive to human PDC-E2 163-176 peptide, the immunodominant autoantigen in primary biliary cirrhosis: implications for molecular mimicry and cross-recognition among mitochondrial autoantigens.
    Shigematsu H; Shimoda S; Nakamura M; Matsushita S; Nishimura Y; Sakamoto N; Ichiki Y; Niho Y; Gershwin ME; Ishibashi H
    Hepatology; 2000 Nov; 32(5):901-9. PubMed ID: 11050037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differing epitope selection of experimentally-induced and natural antibodies to a disease-specific autoantigen, the E2 subunit of pyruvate dehydrogenase complex (PDC-E2).
    Rowley MJ; Maeda T; Mackay IR; Loveland BE; McMullen GL; Tribbick G; Bernard CC
    Int Immunol; 1992 Nov; 4(11):1245-53. PubMed ID: 1282029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.